DE69332856D1 - Haarnadelförmiges ribozym - Google Patents
Haarnadelförmiges ribozymInfo
- Publication number
- DE69332856D1 DE69332856D1 DE69332856T DE69332856T DE69332856D1 DE 69332856 D1 DE69332856 D1 DE 69332856D1 DE 69332856 T DE69332856 T DE 69332856T DE 69332856 T DE69332856 T DE 69332856T DE 69332856 D1 DE69332856 D1 DE 69332856D1
- Authority
- DE
- Germany
- Prior art keywords
- ribozyme
- polyribonucleotide
- forth
- hairpin shaped
- incise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/122—Hairpin
Landscapes
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17570692 | 1992-07-02 | ||
JP23691692 | 1992-09-04 | ||
PCT/JP1993/000907 WO1994001549A1 (en) | 1992-07-02 | 1993-07-02 | Looped, hairpin ribozyme |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69332856D1 true DE69332856D1 (de) | 2003-05-15 |
Family
ID=26496887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332856T Expired - Lifetime DE69332856D1 (de) | 1992-07-02 | 1993-07-02 | Haarnadelförmiges ribozym |
Country Status (8)
Country | Link |
---|---|
US (1) | US5631115A (de) |
EP (1) | EP0653488B1 (de) |
AT (1) | ATE236975T1 (de) |
AU (1) | AU672018B2 (de) |
CA (1) | CA2139411A1 (de) |
DE (1) | DE69332856D1 (de) |
NO (1) | NO311258B1 (de) |
WO (1) | WO1994001549A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19532651A1 (de) * | 1995-09-05 | 1997-03-06 | Aloysius Dr Dickgreber | Mittel zur therapeutischen Anwendung bei HIV-Infektionen |
US5888767A (en) | 1996-11-27 | 1999-03-30 | The Johns Hopkins University School Of Medicine | Method of using a conditionally replicating viral vector to express a gene |
US5885806A (en) * | 1995-11-28 | 1999-03-23 | The Johns Hopkins University School Of Medicine | Methods to prepare conditionally replicating viral vectors |
US6274369B1 (en) * | 1996-02-02 | 2001-08-14 | Invitrogen Corporation | Method capable of increasing competency of bacterial cell transformation |
US8568766B2 (en) | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
WO2002030465A2 (en) | 2000-10-12 | 2002-04-18 | University Of Rochester | Compositions that inhibit proliferation of cancer cells |
EP2311852A1 (de) | 2002-02-06 | 2011-04-20 | Stasys Technologies, Inc. | Anti-Infarkt-Moleküle |
WO2003093452A2 (en) * | 2002-02-26 | 2003-11-13 | University Of Utah Research Foundation | Variants of nedd4l associated with hypertension and viral budding |
CA2374388C (en) | 2002-02-28 | 2005-07-12 | Matthew C. Coffey | The use of ribozymes in the detection of adventitious agents |
US20040005546A1 (en) * | 2002-02-28 | 2004-01-08 | Oncolytics Biotech Inc. | Use of ribozymes in the detection of adventitious agents |
WO2004013160A2 (en) | 2002-08-05 | 2004-02-12 | University Of Rochester | Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
US8512701B2 (en) | 2002-11-15 | 2013-08-20 | Morehouse School Of Medicine | Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration |
US9233120B2 (en) | 2002-11-15 | 2016-01-12 | Jyant Technologies | Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration |
US8658377B2 (en) | 2002-11-15 | 2014-02-25 | Morehouse School Of Medicine | Detecting cancer with anti-CCL25 and anti-CCR9 antibodies |
CA2507863A1 (en) * | 2002-12-04 | 2004-06-17 | Algos Therapeutics, Inc. | Methods and materials for modulating trpm2 |
US8129124B2 (en) | 2005-02-02 | 2012-03-06 | The Uab Research Foundation | Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
SI2567976T1 (sl) | 2005-03-23 | 2017-11-30 | Genmab A/S | Protitelesa usmerjena proti cd38 za zdravljenje multiplega mieloma |
FR2887259B1 (fr) * | 2005-06-21 | 2007-09-14 | Agronomique Inst Nat Rech | CONSTRUCTION D'ADNc D'ALPHAVIRUS DE SALMONIDES |
EP1934244A2 (de) * | 2005-10-06 | 2008-06-25 | Emthrax LLC | Verfahren und zusammensetzungen in verbindung mit milzbrandsporen-glycoproteinen als impfstoffe |
US8093369B2 (en) * | 2005-10-11 | 2012-01-10 | Ben Gurion University Of The Negev Research And Development Authority Ltd. | Compositions for silencing the expression of VDAC1 and uses thereof |
CA2625891A1 (en) | 2005-10-14 | 2007-04-26 | Carlton D. Donald | Inhibition of pax2 by defb1 induction as a therapy for cancer |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
EP2560001B1 (de) | 2006-09-21 | 2016-04-13 | University of Rochester | Zusammensetzungen und Verfahren für eine Proteinverlagerungstherapie für myotone Dystrophie |
US9279127B2 (en) * | 2006-11-01 | 2016-03-08 | The Medical Research Fund At The Tel-Aviv Sourasky Medical Center | Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
EP2104516B1 (de) | 2006-11-01 | 2015-01-07 | University of Rochester | Verfahren und zusammensetzungen in zusammenhang mit der struktur und funktion von apobec3g |
US7994130B2 (en) | 2006-12-11 | 2011-08-09 | University Of Utah Research Foundation | Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability |
US8557767B2 (en) | 2007-08-28 | 2013-10-15 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
JP2010538005A (ja) | 2007-08-28 | 2010-12-09 | ユーエービー リサーチ ファウンデーション | 合成アポリポ蛋白質e模倣ポリペプチドおよび使用方法 |
US8501912B2 (en) * | 2007-12-03 | 2013-08-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Filipil compositions and methods for treating cancer |
US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
EP2853897A1 (de) | 2008-05-08 | 2015-04-01 | University Of Utah Research Foundation | Sensorische Rezeptoren für chronische Müdigkeit und Schmerzen und Verwendungen davon |
EP2370080A1 (de) | 2008-12-02 | 2011-10-05 | University of Utah Research Foundation | Pde1 als zieltherapeutikum bei herzkrankheiten |
US20110060000A1 (en) | 2009-09-10 | 2011-03-10 | Maurizio Grimaldi | Acridine analogs in the treatment of gliomas |
US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
US20160051629A1 (en) | 2013-04-15 | 2016-02-25 | Yeda Research And Development Co. Ltd. | Inhibition of rip kinases for treating lysosomal storage diseases |
BR112017001860A2 (pt) | 2014-07-31 | 2018-02-27 | Uab Research Foundation | peptídeo sintético, composição farmacêutica, métodos, regime de dosagem, e, anticorpo monoclonal |
US10723794B2 (en) | 2015-03-18 | 2020-07-28 | University Of South Carolina | Anti-CcL8 antibodies and uses thereof |
KR20190037273A (ko) | 2016-08-03 | 2019-04-05 | 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 | Tlr9 표적 치료제 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE115999T1 (de) * | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
CA1340323C (en) * | 1988-09-20 | 1999-01-19 | Arnold E. Hampel | Rna catalyst for cleaving specific rna sequences |
-
1993
- 1993-07-02 US US08/367,175 patent/US5631115A/en not_active Expired - Fee Related
- 1993-07-02 AU AU45130/93A patent/AU672018B2/en not_active Ceased
- 1993-07-02 DE DE69332856T patent/DE69332856D1/de not_active Expired - Lifetime
- 1993-07-02 WO PCT/JP1993/000907 patent/WO1994001549A1/ja active IP Right Grant
- 1993-07-02 EP EP93914943A patent/EP0653488B1/de not_active Expired - Lifetime
- 1993-07-02 CA CA002139411A patent/CA2139411A1/en not_active Abandoned
- 1993-07-02 AT AT93914943T patent/ATE236975T1/de not_active IP Right Cessation
-
1994
- 1994-12-30 NO NO19945103A patent/NO311258B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0653488A1 (de) | 1995-05-17 |
AU672018B2 (en) | 1996-09-19 |
US5631115A (en) | 1997-05-20 |
WO1994001549A1 (en) | 1994-01-20 |
NO945103L (no) | 1995-03-02 |
EP0653488B1 (de) | 2003-04-09 |
NO311258B1 (no) | 2001-11-05 |
AU4513093A (en) | 1994-01-31 |
EP0653488A4 (de) | 1997-01-15 |
CA2139411A1 (en) | 1994-01-20 |
NO945103D0 (no) | 1994-12-30 |
ATE236975T1 (de) | 2003-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69332856D1 (de) | Haarnadelförmiges ribozym | |
TR200001892T2 (tr) | Monomer cinsi ensülin analogları ve bunların kullanımı. | |
DE69823481D1 (de) | Wegwerfbare, vorgefüllte medikamentenkartusche | |
BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
NO20034684L (no) | Mikroprojeksjonsanordning med belegg inneholdende et fordelaktig middel | |
ES2177084T3 (es) | Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso. | |
ES2130428T3 (es) | Cristales de insulina asp-b28. | |
BR0109272A (pt) | Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos | |
EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
TR200003113T2 (tr) | 3-(amino- veya aminoalkil) piridinon türevleri ve bunların HIV bağımlı hastalıkların tedavisinde kullanılması. | |
EA200200616A1 (ru) | Химические производные и их применение в качестве антителомеразного агента | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
SE9701161D0 (sv) | New use I | |
PT1001775E (pt) | Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil | |
CY1106235T1 (el) | Χρηση της l-καρνιτινης ως σταθepοποιητικου παραγοντα πρωτεϊνων | |
BR9913982A (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares | |
DE50009838D1 (de) | Humanes antibiotisches protein | |
IT1317930B1 (it) | Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione | |
DE60125232D1 (de) | Kleines säurelösliches sporenprotein und seine verwendungen | |
CY1106702T1 (el) | Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
EA199901061A1 (ru) | Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии | |
HUP0001097A2 (hu) | COMT-inhibitorok alkalmazása cukorbetegséggel kapcsolatos érrendszeri rendellenességek megelőzésére alkalmas gyógyszerkészítmények előállítására | |
FR2818147B1 (fr) | Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |